secwatch / observer
8-K filed September 20, 2024, 7:59 PM ET CIK 0000931059
M&A confidence high sentiment neutral materiality 0.75

Rennova Health, Inc.: M&A transaction — Rennova Health sells two subsidiaries to FOXO; receives $22M note and minimal cash

Rennova Health, Inc.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Rennova Health, Inc. completed a disposition involving FOXO Technologies Inc. for $500,000, payable in shares of FOXO's Class A Common Stock (closed 2024-06-14).

Action
disposition
Counterparty
FOXO Technologies Inc.
Consideration
$500,000, payable in shares of FOXO's Class A Common Stock
Closing
2024-06-14
Exact text from the filing
The first agreement (the “Myrtle Agreement”) provided for the Company to exchange all of its equity interest in its subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”) for $500,000, payable in shares of FOXO’s Class A Common Stock (the “FOXO Common Stock”). This transaction closed on June 14, 2024. On June 25, 2024, the parties to the Myrtle Agreement
View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR
accession 0001493152-24-037606
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.